Proactive management with topical corticosteroids ointment in pediatric atopic dermatitis : Superiority to rank-down therapy
- Conditions
- atopic dermatitis
- Registration Number
- JPRN-UMIN000031979
- Lead Sponsor
- Jichi Medical University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 90
Not provided
Patients meeting any of the following criteria are not to be enrolled in the study. (1) Patients with skin infections caused by bacteria, fungi, spirochetes or viruses and patients with ectoparasitic skin diseases (scabies, pubic lice, etc.). (2)History of hypersensitivity to any components of the topical steroid and/or moisturizer to be used (3) Patients with ulcers (except for Bechet's disease) and patients with deep burns or frostbite of second degree or higher. (4) Patients complicated with an active infection in the area the study drug is to be applied. (5) Patients complicated with Kaposi's varicelliform eruption, scabies, molluscum contagious, psoriasis, disorders (Netherton syndrome, etc.) presenting with ichthyosiform erythroderma, collagen disease (SLE and dermatomyositis), and skin disorder on the area study drug is to be applied to, which can affect evaluation. (6) Patients who used the following drug within 28 days prior to Visit 1 (at the time of informed consent) > Systemic adrenocortical steroid (oral, injectable, suppository, and inhaled) > Topical steroid (strongest) > Systemic immunosuppressant > Live vaccine (7) Patients who received phototherapy (UVB, Narrow-band UVB, PUVA , etc.) within 28 days prior to Visit 1 (at the time of informed consent) (8) Patients who participated in another clinical trial (including clinical trial of medical device) or clinical research involving intervention within 12 weeks prior to Visit 1 (at the time of informed consent) (9) Patients determined by the investigator to be unsuitable for the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method